Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cosopt Add-on to Latanoprost in Glaucoma
NCT00957190Phase 4Completed
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- May 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dorzolamide + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Hôpital Maisonneuve-Rosemont. Started May 2009; status: completed.
02
Drugs
dorzolamide + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00957190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957190.